Summary
The Trump administration recently released its Spring 2025 Unified Agenda, which outlines regulatory plans for federal agencies over the coming year. The Unified Agenda reflects the administration’s priority on policies addressing health. In our regulatory outlook, we highlight rulemaking on coverage and payment, mental and behavioral health, prescription drug prices, health IT, public health and safety, and more.
- What it is. The Spring 2025 edition of the semiannual unified agenda contains regulatory actions that federal agencies plan to undertake in the next 12 months. The Unified Agenda includes annual regulatory updates (e.g., Medicare payment policies); regulations implementing recently enacted laws; and regulations implementing Executive Orders (EOs) and other priorities, such as regulatory proposals in the President’s Budget.
Each entry is organized by federal agency and its stage in the rulemaking process – prerule stage (e.g., Advanced Notices of Proposed Rulemaking), proposed rule stage (e.g., Notice of Proposed Rulemaking), final rule stage, long-term actions, and completed actions.
We include entries from the following departments and agencies:
- Department of Health and Human Services (HHS) – administration for Children and Families (ACF), Centers for Medicare and Medicaid Services (CMS), Food and Drug administration, Office for Civil Rights (OCR), Office of the Assistant Secretary for Health (OASH), Office of Inspector General (OIG), Office of the National Coordinator for Health Information Technology (ONC), Office of the Secretary (OS), and Substance Abuse and Mental Health Services administration (SAMHSA)
- Department of Labor (DOL) – Employee Benefits Security administration (EBSA) and Occupational Safety and Health administration (OSHA);
- Department of Treasury – Internal Revenue Service (IRS);
- Department of Agriculture – Food and Nutrition Service (FNS) and Rural Housing Service (RHS);
- Department of Housing and Urban Development (HUD) – various agencies;
- Department of Justice (DOJ) – Drug Enforcement administration (DEA);
- Federal Trade Commission (FTC);
- Office of Management and Budget (OMB); and
- Small Business administration (SBA).
- Why it is important for you. As a roadmap of the Trump administration’s regulatory priorities, the Unified Agenda enables stakeholders to anticipate and prepare for rulemaking. Stakeholders can participate in the process by requesting an EO 12866 meeting with OMB and/or submitting public comments. The projected dates for regulatory actions may shift (likely later than scheduled), but they are helpful guides for advocacy planning.
- Next steps. Impact Health flags regulatory actions as they move through the process, specifically when they reach OMB for review and when regulatory review is completed. We include these updates in our Weekly sent on Mondays. For each policy area below, we note the lead Impact Health team members that can answer any questions or provide additional assistance.